• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西副球孢子菌高分子量(hMM)组分在BALB/c小鼠中诱导的保护作用。

Protection induced in BALB/c mice by the high-molecular-mass (hMM) fraction of Paracoccidioides brasiliensis.

作者信息

Pavanelli Wander R, Kaminami Mari S, Geres Juliana R, Sano Ayako, Ono Mario A, Camargo I C C, Itano Eiko N

机构信息

Fundação Araucária, Curitiba, PR, Brazil.

出版信息

Mycopathologia. 2007 Mar;163(3):117-28. doi: 10.1007/s11046-007-0095-4. Epub 2007 Mar 14.

DOI:10.1007/s11046-007-0095-4
PMID:17356792
Abstract

Paracoccidioidomycosis (PCM) is a granulomatous disease caused by a dimorphic fungus, Paracoccidioides brasiliensis. The present study investigated the protective activity of the P. brasiliensis high-molecular-mass (hMM) fraction (approximately 380 kDa) in experimental murine PCM. In the first step, lymphocyte proliferation and production of IFNgamma (but not IL-4) were observed in "in vitro" spleen cells (from female BALB/c mice infected (i.v.) with P. brasiliensis) that were stimulated with hMM fractions. In the second step, female BALB/c mice were previously immunized (s.c.) with hMM fraction (25 microg/protein = F-25 and 50 microg/protein = F-50), and the colony-forming units (CFU) of the lung and spleen, the histopathological characteristics of the granulomatous lesions, and plasmatic gp43 soluble antigens and anti-hMM IgG levels were analyzed at 28 and 56 days after infection. The lung and liver CFU were lower in mice previously immunized with the hMM fraction (P < 0.05). The granulomatous lesions revealed a greater degree of compaction and organization, with no dissemination of the fungus to other organs. Lower soluble antigen levels (P < 0.05) and higher IgG anti-hMM fraction (P < 0.05) were observed in immunized groups. The results for CFU, histopathology and antigenemia suggest that the hMM fraction has a protective effect in experimental paracoccidioidomycosis in BALB/c mice.

摘要

副球孢子菌病(PCM)是一种由双相真菌巴西副球孢子菌引起的肉芽肿性疾病。本研究调查了巴西副球孢子菌高分子量(hMM)组分(约380 kDa)在实验性小鼠PCM中的保护活性。第一步,在用hMM组分刺激的“体外”脾细胞(来自经静脉注射巴西副球孢子菌感染的雌性BALB/c小鼠)中观察到淋巴细胞增殖和IFNγ(而非IL-4)的产生。第二步,雌性BALB/c小鼠预先皮下注射hMM组分(25μg/蛋白 = F-25和50μg/蛋白 = F-50),并在感染后28天和56天分析肺和脾的菌落形成单位(CFU)、肉芽肿病变的组织病理学特征、血浆gp43可溶性抗原和抗hMM IgG水平。预先用hMM组分免疫的小鼠肺和肝CFU较低(P < 0.05)。肉芽肿病变显示出更高程度的致密性和组织化,真菌未扩散至其他器官。在免疫组中观察到较低的可溶性抗原水平(P < 0.05)和较高的抗hMM组分IgG(P < 0.05)。CFU、组织病理学和抗原血症的结果表明,hMM组分在BALB/c小鼠实验性副球孢子菌病中具有保护作用。

相似文献

1
Protection induced in BALB/c mice by the high-molecular-mass (hMM) fraction of Paracoccidioides brasiliensis.巴西副球孢子菌高分子量(hMM)组分在BALB/c小鼠中诱导的保护作用。
Mycopathologia. 2007 Mar;163(3):117-28. doi: 10.1007/s11046-007-0095-4. Epub 2007 Mar 14.
2
Cyclosporin A treatment and decreased fungal load/antigenemia in experimental murine paracoccidioidomycosis.环孢素 A 治疗和实验性变应性真菌病中真菌负荷/抗原血症减少。
Mycopathologia. 2011 Mar;171(3):161-9. doi: 10.1007/s11046-010-9359-5. Epub 2010 Sep 11.
3
Protective immunity induced by rPb27 of Paracoccidioides brasiliensis.巴西副球孢子菌rPb27诱导的保护性免疫。
Vaccine. 2008 Oct 9;26(43):5461-9. doi: 10.1016/j.vaccine.2008.07.097. Epub 2008 Aug 21.
4
Protective immunity induced in mice by F0 and FII antigens purified from Paracoccidioides brasiliensis.从巴西副球孢子菌中纯化的F0和FII抗原在小鼠中诱导的保护性免疫。
Vaccine. 2004 Jan 2;22(3-4):485-92. doi: 10.1016/j.vaccine.2003.07.017.
5
Recombinant vaccines of a CD4+ T-cell epitope promote efficient control of Paracoccidioides brasiliensis burden by restraining primary organ infection.一种CD4 + T细胞表位的重组疫苗通过抑制原发性器官感染促进对巴西副球孢子菌负荷的有效控制。
PLoS Negl Trop Dis. 2017 Sep 22;11(9):e0005927. doi: 10.1371/journal.pntd.0005927. eCollection 2017 Sep.
6
Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin.基于gp43衍生的P10序列和肠炎沙门氏菌鞭毛蛋白FliC的巴西副球孢子菌疫苗制剂。
Infect Immun. 2009 Apr;77(4):1700-7. doi: 10.1128/IAI.01470-08. Epub 2009 Feb 9.
7
Immunization with recombinant Pb27 protein reduces the levels of pulmonary fibrosis caused by the inflammatory response against Paracoccidioides brasiliensis.用重组Pb27蛋白进行免疫可降低由针对巴西副球孢子菌的炎症反应所引起的肺纤维化水平。
Mycopathologia. 2015 Feb;179(1-2):31-43. doi: 10.1007/s11046-014-9815-8. Epub 2014 Dec 9.
8
Adjuvant effect of synthetic oligodeoxyribonucleotides (CpG-ODN) from the Paracoccidioides brasiliensis gp43 gene on the Th2-Th1 immunomodulation of experimental paracoccidioidomycosis.巴西副球孢子菌gp43基因合成寡脱氧核糖核苷酸(CpG-ODN)对实验性副球孢子菌病Th2-Th1免疫调节的佐剂作用
Scand J Immunol. 2005 Oct;62(4):325-33. doi: 10.1111/j.1365-3083.2005.01680.x.
9
The combined use of Paracoccidioides brasiliensis Pb40 and Pb27 recombinant proteins enhances chemotherapy effects in experimental paracoccidioidomycosis.巴西副球孢子菌 Pb40 和 Pb27 重组蛋白联合使用可增强实验性副球孢子菌病的化疗效果。
Microbes Infect. 2011 Nov;13(12-13):1062-72. doi: 10.1016/j.micinf.2011.06.004. Epub 2011 Jun 21.
10
Saccharomyces cerevisiae expressing Gp43 protects mice against Paracoccidioides brasiliensis infection.表达Gp43的酿酒酵母可保护小鼠免受巴西副球孢子菌感染。
PLoS One. 2015 Mar 19;10(3):e0120201. doi: 10.1371/journal.pone.0120201. eCollection 2015.

引用本文的文献

1
Unraveling the Nano World in Paracoccidioidomycosis: Promising Applications of Nanotechnology in Diagnosis, Treatment, and Vaccines: A Mini Review.揭开副球孢子菌病中的纳米世界:纳米技术在诊断、治疗和疫苗方面的应用前景:一篇综述短文
Curr Microbiol. 2025 Apr 28;82(6):264. doi: 10.1007/s00284-025-04251-9.
2
Paracoccidioides brasiliensis and P. lutzii antigens elicit different serum IgG responses in chronic paracoccidioidomycosis.巴西副球孢子菌和卢氏副球孢子菌抗原在慢性副球孢子菌病中引起不同的血清 IgG 反应。
Mycopathologia. 2013 Dec;176(5-6):345-52. doi: 10.1007/s11046-013-9698-0. Epub 2013 Sep 5.
3
New advances in the development of a vaccine against paracoccidioidomycosis.

本文引用的文献

1
Drug-drug interactions of antifungal agents and implications for patient care.抗真菌药物的药物相互作用及其对患者护理的影响。
Expert Opin Pharmacother. 2005 Oct;6(13):2231-43. doi: 10.1517/14656566.6.13.2231.
2
Reactivity of antibodies from patients with acute and chronic paracoccidioidomycosis to a high molecular mass antigen from Paracoccidioides brasiliensis.急性和慢性副球孢子菌病患者的抗体对巴西副球孢子菌一种高分子量抗原的反应性。
J Clin Lab Anal. 2005;19(5):199-204. doi: 10.1002/jcla.20078.
3
Protective immunity induced in mice by F0 and FII antigens purified from Paracoccidioides brasiliensis.
抗副球孢子菌病疫苗研发的新进展。
Front Microbiol. 2012 Jun 12;3:212. doi: 10.3389/fmicb.2012.00212. eCollection 2012.
4
Cyclosporin A treatment and decreased fungal load/antigenemia in experimental murine paracoccidioidomycosis.环孢素 A 治疗和实验性变应性真菌病中真菌负荷/抗原血症减少。
Mycopathologia. 2011 Mar;171(3):161-9. doi: 10.1007/s11046-010-9359-5. Epub 2010 Sep 11.
从巴西副球孢子菌中纯化的F0和FII抗原在小鼠中诱导的保护性免疫。
Vaccine. 2004 Jan 2;22(3-4):485-92. doi: 10.1016/j.vaccine.2003.07.017.
4
Characterization of gp70 and anti-gp70 monoclonal antibodies in Paracoccidioides brasiliensis pathogenesis.巴西副球孢子菌致病过程中gp70及抗gp70单克隆抗体的特性分析
Infect Immun. 2003 Nov;71(11):6534-42. doi: 10.1128/IAI.71.11.6534-6542.2003.
5
The role of apoptosis in the antigen-specific T cell hyporesponsiveness of paracoccidioidomycosis patients.
Clin Immunol. 2002 Nov;105(2):215-22. doi: 10.1006/clim.2002.5272.
6
Paracoccidioidomycosis mortality in Brazil (1980-1995).巴西的副球孢子菌病死亡率(1980 - 1995年)。
Cad Saude Publica. 2002 Sep-Oct;18(5):1441-54. doi: 10.1590/s0102-311x2002000500037.
7
Levels of specific antigen (gp43), specific antibodies, and antigen-antibody complexes in saliva and serum of paracoccidioidomycosis patients.
Med Mycol. 2001 Oct;39(5):423-8. doi: 10.1080/mmy.39.5.423.428.
8
Cytokines and lymphocyte proliferation in juvenile and adult forms of paracoccidioidomycosis: comparison with infected and non-infected controls.副球孢子菌病青少年和成人形式中的细胞因子与淋巴细胞增殖:与感染及未感染对照的比较
Microbes Infect. 2002 Feb;4(2):139-44. doi: 10.1016/s1286-4579(01)01521-0.
9
Antifungal compounds: controversies, queries and conclusions.
Med Mycol. 2000;38 Suppl 1:323-33.
10
The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections.获得性体液免疫和细胞免疫在实验性真菌感染预防和治疗中的功效。
Med Mycol. 2000;38 Suppl 1:281-92.